Trial intelligence / Profile preview

Oral Defense Toothpaste for Chemotherapy-Induced Oral Mucositis

NCT02606994Phase 2Terminated

Start
May 2018
Primary completion
Feb 2019
Countries
1
01

Overview

Phase 2, randomised, open-label trial in oral mucositis (OM) (2 arms). Primary endpoint: Oral mucositis changes at Day 8. Started May 2018; status: terminated.

02

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT02606994.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02606994.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call